Medical imaging plays a prominent role in clinical trials as it can help in providing answers to the critical challenges that occur in drug development process. It takes about 15 years for a drug to move from a laboratory set-up to FDA approval. The chances of a compound getting regulatory approval are minimal as out of 6 to 11,000 compounds that are evaluated in the pre-clinical stage, only 5 are able to make it to the clinical trials and only one of them gets regulatory approval. Medical imaging can help play a crucial role in the product development process as it can reduce the late-stage attrition by gathering more information in the pre-clinical trials of safety, efficacy, and mechanism of action. Request Sample Of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=20354 Medical imaging applications for pharmaceutical clinical trials include identifying disease predisposition, diagnosing and evaluating lesions and their severity, deter...
Today, healthcare organizations operate in a dynamic ecosystem, wherein they are required to adopt unprecedented advancements for diagnostics and therapeutics, every now and then. Healthcare organizations are facing the uphill task to incorporate technological driven processes, and deliver managed care to the discerning consumer.